5-ethoxy-3'-((((R)-2-((R)-1-(N-hydroxyformamido)propyl)heptanamido)methyl)carbamoyl)-[1,1'-biphenyl]-3-sulfonic acid

ID: ALA4580275

Chembl Id: CHEMBL4580275

PubChem CID: 145227814

Max Phase: Preclinical

Molecular Formula: C27H37N3O8S

Molecular Weight: 563.67

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCC[C@@H](C(=O)NCNC(=O)c1cccc(-c2cc(OCC)cc(S(=O)(=O)O)c2)c1)[C@@H](CC)N(O)C=O

Standard InChI:  InChI=1S/C27H37N3O8S/c1-4-7-8-12-24(25(5-2)30(34)18-31)27(33)29-17-28-26(32)20-11-9-10-19(13-20)21-14-22(38-6-3)16-23(15-21)39(35,36)37/h9-11,13-16,18,24-25,34H,4-8,12,17H2,1-3H3,(H,28,32)(H,29,33)(H,35,36,37)/t24-,25-/m1/s1

Standard InChI Key:  DZYZONWMNGRQTN-JWQCQUIFSA-N

Alternative Forms

  1. Parent:

    ALA4580275

    ---

Associated Targets(Human)

BMP1 Tchem Bone morphogenetic protein 1 (1282 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLL1 Tchem Tolloid-like protein 1 (400 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLL2 Tchem Tolloid-like protein 2 (396 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 563.67Molecular Weight (Monoisotopic): 563.2301AlogP: 3.63#Rotatable Bonds: 16
Polar Surface Area: 162.34Molecular Species: ACIDHBA: 7HBD: 4
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: -2.29CX Basic pKa: CX LogP: 1.70CX LogD: 1.12
Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.06Np Likeness Score: -0.34

References

1.  (2017)  Hydroxy formamide derivatives and their use, 

Source